IRIS
DALLABONA, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.736
AS - Asia 2.837
EU - Europa 2.586
SA - Sud America 425
AF - Africa 139
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 9.735
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.666
SG - Singapore 1.125
CN - Cina 1.000
IT - Italia 786
SE - Svezia 449
IE - Irlanda 424
BR - Brasile 346
HK - Hong Kong 272
FI - Finlandia 225
DE - Germania 157
VN - Vietnam 149
NL - Olanda 114
ZA - Sudafrica 105
FR - Francia 100
GB - Regno Unito 87
RU - Federazione Russa 69
TR - Turchia 63
UA - Ucraina 60
BD - Bangladesh 55
IN - India 50
CA - Canada 40
AR - Argentina 36
BE - Belgio 29
AT - Austria 25
MX - Messico 21
KR - Corea 19
PL - Polonia 18
ES - Italia 14
JP - Giappone 14
ID - Indonesia 13
EC - Ecuador 12
PK - Pakistan 12
CI - Costa d'Avorio 10
UZ - Uzbekistan 10
IR - Iran 9
MA - Marocco 9
IQ - Iraq 8
LT - Lituania 8
VE - Venezuela 8
IL - Israele 7
AZ - Azerbaigian 6
CO - Colombia 6
EU - Europa 6
PE - Perù 6
KE - Kenya 5
TW - Taiwan 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
EG - Egitto 4
PT - Portogallo 4
SA - Arabia Saudita 4
AU - Australia 3
CL - Cile 3
DK - Danimarca 3
LB - Libano 3
LK - Sri Lanka 3
GE - Georgia 2
JM - Giamaica 2
NI - Nicaragua 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CR - Costa Rica 1
DZ - Algeria 1
GT - Guatemala 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
PW - Palau 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.735
Salva come PNG Salva come JPEG
Città #
Singapore 546
Ashburn 419
Dublin 413
Dallas 406
Santa Clara 379
Chandler 376
Beijing 279
Hong Kong 263
Parma 201
Ann Arbor 172
Boardman 157
Dearborn 142
Johannesburg 97
Los Angeles 91
Shanghai 88
Jacksonville 83
New York 81
Nanjing 79
Hefei 75
Princeton 69
Ho Chi Minh City 59
Izmir 54
Moscow 44
Wilmington 43
Milan 39
Columbus 38
Bologna 37
Munich 36
Helsinki 34
Des Moines 31
Jinan 31
Shenyang 29
Brussels 28
Nanchang 28
São Paulo 28
Hanoi 26
San Mateo 26
Woodbridge 25
Nuremberg 24
Kunming 23
Marseille 22
Changsha 19
Seoul 19
Toronto 19
Guangzhou 18
Hebei 18
Turku 17
Colchester 15
Hangzhou 15
Houston 15
Tianjin 15
Vienna 15
Belo Horizonte 14
Falls Church 14
Seattle 14
Tokyo 14
Warsaw 14
Zhengzhou 14
Brooklyn 13
Buffalo 13
Redmond 13
Rome 13
The Dalles 13
Catania 12
Chicago 12
Atlanta 11
Fontanellato 11
London 11
Phoenix 11
Abidjan 10
Bengaluru 10
Frankfurt am Main 10
Piacenza 10
Tashkent 10
Bremen 9
Jakarta 9
Mexico City 9
Pistoia 9
Rio de Janeiro 9
Bari 8
Biên Hòa 8
Norwalk 8
Pune 8
Stockholm 8
Vicenza 8
Washington 8
Carpi 7
Curitiba 7
Denver 7
Gravina di Catania 7
Guarulhos 7
Newark 7
Reggio Emilia 7
San Francisco 7
Vezzano sul Crostolo 7
Baku 6
Boston 6
Brescia 6
Chennai 6
Council Bluffs 6
Totale 5.767
Salva come PNG Salva come JPEG
Nome #
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 169
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 169
DNA polymerase [gamma] and disease: what we have learned from yeast 168
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 152
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 147
Yeast as a model system to shed light on the role of the human disease protein Mpv17 142
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 142
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration 141
Elongator-dependent modification of cytoplasmic tRNALysUUU is required for mitochondrial function under stress conditions 140
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 140
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 137
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 136
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 135
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 135
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis and severe reduction of mitochondrial complex III activity. 135
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 134
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 134
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 132
Yeast as a model system for diseases associated with defective coenzyme a metabolism 131
A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature 130
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 130
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 127
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 127
YEAST MODEL FOR NOVEL AARS2 MUTATIONS ASSOCIATED WITH PROGRESSIVE LEUKOENCEPHALOPATHY AND CEREBELLAR ATAXIA 124
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 123
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae 121
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 116
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 115
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 114
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 113
Characterization of the Saccharomyces cerevisiae SYM1 gene, ortholog of the human desease gene MPV17 113
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 113
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 113
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 112
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 110
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 110
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies 108
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 108
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 107
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 106
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 104
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 104
Uncovering a Novel Pathogenic Mechanism of BCS1L in Mitochondrial Disorders: Insights from Functional Studies on the c.38A>G Variant. 103
SYM1, l'ortologo di lievito del gene umano MPV17, codifica per una proteina indotta da stress che modula lo stato bioenergetico e morfogenetico del mitocondrio 103
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 103
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 102
MUTATIONS IN THE GENES QRSL1, GATB, AND GATC ENCODING THE SUBUNITS OF GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE CAUSE A MITOCHONDRIAL DISORDER WITH LETHAL INFANTILE CARDIOMYOPATHY 102
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 101
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. 101
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 101
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 100
VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies 100
Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy 100
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration 99
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 99
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined Nonketotic Hyperglycinemia and Lipoate Deficiency 98
Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations 98
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 96
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 96
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 96
Yeast models of human MTO1 variants confirm two diagnoses of mitochondrial modopathy 95
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 94
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 94
The power of yeast in modeling human mutations leading to mitochondrial disease 91
Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation 89
Childhood obsessive-compulsive disorder, epigenetics, and heterochrony: An evolutionary and developmental approach 89
MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast 89
Epigenetic alterations in prescription opioid misuse: New strategies for precision pain management 85
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. 84
The Saccharomyces cerevisiae yeast as a model system to study the human mitochondrial DNA depletion syndromes (MDDS) 83
Epigenetic analyses in forensic medicine: future and challenges 83
MITMED: A MULTICENTER CONSORTIUM FOR THE IDENTIFICATION AND CHARACTERIZATION OF NUCLEAR GENES RESPONSIBLE FOR HUMAN MITOCHONDRIAL DISORDERS 82
Mitochondrial diseases and the role of the yeast models. 80
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number 79
A potential link between inflammatory profiles, clinical pain, pain catastrophizing and long‐term outcomes after total knee arthroplasty surgery 77
Characterization of the BCS1L c.38A>G variant identified in a patient with Biörnstad syndrome 77
Transcriptomics on yeast models to deepen the knowledge of mitochondrial disease-associated pathways 77
Saccharomyces cerevisiae: a powerful organism to study mitochondrial diseases and support mitochondrial medicine 77
De novo DNM1L pathogenic variant associated with lethal encephalocardiomyopathy and a literature review 76
Role of ROS in mtDNA instability in ANT1-associated adPEO 76
Repurposing Drugs for Mitochondrial Disorders: A Yeast-Based Approach for Complex III Assembly Defects 74
The yeast Saccharomyces cerevisiae as a model to deepen the knowledge about the mitochondrial metallopeptidase PITRM1 in health and disease 73
A simple organism to address big questions: how Saccharomyces cerevisiae can support mitochondrial medicine 72
Yeast-based screening to discover therapies for Complex III assembly defects. 71
The first recessive pathological mutation in the adenine nucleotide translocator: yeast as a model system 71
Phenotypic, molecular, and functional characterization of COQ7-related primary CoQ10 deficiency: Hypomorphic variants and two distinct disease entities 71
Novel (ovario) leukodystrophy related to AARS2 mutations 69
Identification of potential therapeutic compounds for mitochondrial disorders due to mutations in mitochondrial respiratory chain assembly factors by exploiting yeast models 68
De Novo DNM1L Pathogenic Variant Associated with Lethal Encephalocardiomyopathy—Case Report and Literature Review 66
The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders 66
The polymorphism Val158Met in the COMT gene: disrupted dopamine system in fibromyalgia patients? 65
An Unusual Case of SUCLA2-related Mitochondrial DNA Depletion Syndrome Who Presented with Hepatopathy Following Chemotherapy: Molecular Analysis and Functional Study 64
Pain mechanistic networks: the development using supervised multivariate data analysis and implications for chronic pain 61
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis 60
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 58
Yeast model of mitochondrial involvement of Aβ amyloidotic neurodegeneration 55
Targeting defects in assembly of the mitochondrial respiratory chain complexes by exploiting yeast models 52
MTO1 MUTATIONS CAUSE RESPIRATORY CHAIN DEFICIENCY IN HUMANS AND YEAST 52
From Genetics to Epigenetics: The Steps of a Path 2
Totale 10.012
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021382 0 0 0 0 48 31 23 23 106 61 53 37
2021/2022407 22 21 1 27 14 27 36 37 14 33 28 147
2022/20231.478 141 151 102 96 136 157 28 83 505 7 51 21
2023/2024764 57 66 37 29 58 146 39 64 17 74 66 111
2024/20252.559 44 91 123 143 291 388 142 116 359 205 193 464
2025/20262.643 480 529 733 487 414 0 0 0 0 0 0 0
Totale 10.012